Second Booster Shot for Americans Over 50 Authorized by FDA
Second Booster Shot for Americans Over 50 Authorized by FDA
Second Booster Shot for , Americans Over 50 Authorized by FDA.
Second Booster Shot for , Americans Over 50 Authorized by FDA.
'USA Today' reports the FDA says Americans 50 and older will now be eligible to receive another round of coronavirus vaccine booster shots.
Based on an analysis of emerging data, a second booster dose of either the Pfizer-BioNTech or.., Dr. Peter Marks, director of FDA's Center for Biologics Evaluation and Research, via statement.
... Moderna COVID-19 vaccine could help increase protection levels for these higher-risk individuals.
, Dr. Peter Marks, director of FDA's Center for Biologics Evaluation and Research, via statement.
The FDA says another booster dose will offer added protection against severe COVID-19 infections.
Though it shouldn't be necessary until at least four months after the first is received.
Though it shouldn't be necessary until at least four months after the first is received.
The Centers for Disease Control and Prevention (CDC) has yet to authorize the shot.
Getting another booster shot at this point in the COVID-19 pandemic, some experts say, is purely a personal decision.
Getting another booster shot at this point in the COVID-19 pandemic, some experts say, is purely a personal decision.
Obviously, the older you are, the higher the risk; and the more underlying conditions, the higher the risk, Dr. Tom Frieden, former director of CDC, via 'USA Today'.
Studies have shown coronavirus vaccines to be safe and effective in protecting against death and severe illness.
The FDA has determined that the known and potential benefits of a second COVID-19 vaccine booster dose with either of these vaccines outweigh their known and potential risks in these populations.
, Dr. Tom Frieden, former director of CDC, via 'USA Today'.
The FDA has determined that the known and potential benefits of a second COVID-19 vaccine booster dose with either of these vaccines outweigh their known and potential risks in these populations.
, Dr. Tom Frieden, former director of CDC, via 'USA Today'
